[1] Khaja A M, Grotta J C. Established treatments for acute ischemic stroke[J]. Lancet, 2007, 369(9558):319-330.[2] Zhao H, Sapolsky R M, Steinberg G K. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats[J]. J Cereb Blood Flow Metab, 2006, 26(9):1114-1121.[3] Zhao H, Luo Y, Liu X, et al. Ischemic post-conditioning partially reverses cell cycle reactivity following ischemia/reperfusion injury: a genome-wide survey[J]. CNS Neurol Disord Drug Targets, 2013, 12(3):350-359.[4] Loddick S A, Turnbull A V, Rothwell N J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J]. J Cereb Blood Flow Metab, 1998, 18(2):176-179.[5] Gaub P, Tedeschi A, Puttagunta R, et al. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation[J]. Cell Death Differ, 2010, 17(9):1392-1408.[6] Gomes F C, Paulin D, Moura N V. Glial fibrillary acidic protein(GFAP): modulation by growth factors and its implication in astrocyte differentiation[J]. Braz J Med Biol Res, 1999, 32(5):619-631.[7] Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1):84-91.[8] Wang W, Redecker C, Yu Z Y, et al. Rat focal cerebral ischemia induced astrocyte proliferation and delayed neuronal death are attenuated by cyclin-dependent kinase inhibition[J]. J Clin Neurosci, 2008, 15(3):278-285.[9] Bahan S, Bachleda A, Morrison R S, et a1. Expression of histone deacetylases in cellular compartments of the mouse brain and the effects of ischemia[J]. Transl Stroke Res, 2011, 2(3):411-423.[10] Yildirim F, Gertz K, Kronenberg G, et al. Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury[J]. Exp Neurol, 2008, 210(2):531-542.[11] Kim H J, Rowe M, Ren M, et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action[J]. J Pharmacol Exp Ther, 2007, 321(3):892-901.[12] Faraco G, Pancani T, Formentini L, et al. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain[J]. Mol Pharmacol, 2006, 70(6):1876-1884.[13] 张迪, 任长虹, 吉训明, 等.脑缺血-再灌注损伤后的炎性反应过程及机制的研究进展[J].中国脑血管病杂志, 2013, 10(7):383-387.[14] 戚智锋, 师文娟, 闫峰, 等.羟基红花黄色素A对脑缺血-再灌注大鼠星形胶质细胞活性的影响[J].中国脑血管病杂志, 2013, 10(9):488-491. |